Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideGILDGilead Sciences
FinDog View：Neutral
| Metric | AMGN | GILD |
|---|
| Close | 376.35 | 147.68 |
| Market Cap | $203B | $183B |
| 1M | −10.26% | +6.31% |
| P/E (TTM) | 23.3 | — |
| Forward P/E | 16.9 | 25.3 |
| P/E 5-Yr Percentile | 27 | — |
| P/S | 5.4 | 6.0 |
| P/B | 17.4 | 15.3 |
| Dividend Yield | 3.21% | 3.98% |
| Latest Quarter Revenue | $10.1B | $7.8B |
| Revenue YoY | +9.5% | +10.2% |
| Gross Margin | 72.0% | 79.8% |
| Latest Quarter EPS | 4.37 | -8.45 |
| Avg Post-Earnings Move | ±5.2% | ±3.8% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.60% | 3.01% |
| 90-Day Net Insider Buying | −$4.1M | −$15.4M |
AMGN · Revenue, Last 8 Quarters ($B)
GILD · Revenue, Last 8 Quarters ($B)
